longbridge

ArriVent Biopharma

AVBP
----

All Shareholders

Shareholder Type

  • Institutions66.80%
  • Hedge funds17.28%
  • VC/PE firms13.43%
  • Individuals & Insiders1.73%
  • Private companies0.76%

Major Shareholders

Major Shareholders Latest
Shareholder
Montanova Capital, LLC
9.16%4.52M0.56%+114.45K
Infinitum Asset Management, LLC
9.00%4.44M0.16%+289.46K
Hillhouse Investment Management, Ltd.
7.97%3.93M0.70%+0
BlackRock, Inc.
6.59%3.25M1.01%+720.10K
OrbiMed Advisors LLC
6.14%3.03M0.54%+0
FMR LLC
5.64%2.78M1.02%-237.24K
HBM Healthcare Investments AG
4.45%2.20M0.39%+0
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
4.15%2.05M0.37%+0
Vanguard Capital Management, LLC
4.13%2.03M0.27%+288.14K
Octagon Capital Advisors LP
4.00%1.97M0.35%+0
Sofinnova Investments, Inc.
3.44%1.70M0.30%+0
State Street Investment Management
3.43%1.69M0.30%+271.57K
Vivo Capital, LLC
3.41%1.68M1.46%+796.18K
Novo Holdings A/S
3.04%1.50M1.24%-442.14K
General Catalyst Group Management, LLC
3.03%1.49M0.27%+0
Logos Global Management, L.P.
2.03%1.00M1.26%+650.00K
Geode Capital Management, LLC
1.97%972.63K0.20%+168.97K
D. E. Shaw & Co., L.P.
1.77%872.01K0.95%+503.22K
HongShan Capital Advisors Limited
1.35%663.31K0.12%+0
Point72 Asset Management, L.P.
1.15%566.80K0.50%-181.40K
© 2026 Longbridge｜Terms of ServicePrivacy Policy